143 related articles for article (PubMed ID: 1828024)
1. Thirst and plasma levels of vasopressin, angiotensin II and atrial natriuretic peptide in patients with non-insulin-dependent diabetes mellitus.
Kamoi K; Ishibashi M; Yamaji T
Diabetes Res Clin Pract; 1991 Mar; 11(3):195-202. PubMed ID: 1828024
[TBL] [Abstract][Full Text] [Related]
2. Dependent effect of drinking volume on vasopressin but not atrial peptide in humans.
Williams TD; Seckl JR; Lightman SL
Am J Physiol; 1989 Oct; 257(4 Pt 2):R762-4. PubMed ID: 2529782
[TBL] [Abstract][Full Text] [Related]
3. Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome.
Shin SJ; Lee YJ; Hsiao PJ; Tsai JH
Diabetes Care; 1999 Jul; 22(7):1181-5. PubMed ID: 10388986
[TBL] [Abstract][Full Text] [Related]
4. Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humans.
Burrell LM; Lambert HJ; Baylis PH
Am J Physiol; 1991 Mar; 260(3 Pt 2):R475-9. PubMed ID: 1825748
[TBL] [Abstract][Full Text] [Related]
5. Effect of atrial natriuretic hormone on vasopressin and thirst response to osmotic stimulation in human subjects.
Wazna-Wesly JM; Meranda DL; Carey P; Shenker Y
J Lab Clin Med; 1995 Jun; 125(6):734-42. PubMed ID: 7769367
[TBL] [Abstract][Full Text] [Related]
6. Effects of posture on the plasma hormonal and renal water-electrolyte excretory responses to acute water loading in diabetic subjects with hypoadrenergic orthostatic hypotension.
Nakano S; Ishii T; Kitazawa M; Kigoshi T; Uchida K; Morimoto S
J Diabetes Complications; 1996; 10(5):274-9. PubMed ID: 8887016
[TBL] [Abstract][Full Text] [Related]
7. Rebound increase in plasma renin and vasopressin following graded infusions of atrial natriuretic peptide in man.
Williams TD; Walsh KP; Pitts E; Sutton R; Lightman SL
J Endocrinol Invest; 1988 Jan; 11(1):31-5. PubMed ID: 2966190
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease.
Elias AN; Vaziri ND; Pandian MR; Kaupke J
Int J Artif Organs; 1989 Mar; 12(3):153-8. PubMed ID: 2526100
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide inhibits postural release of renin and vasopressin in humans.
Williams TD; Walsh KP; Lightman SL; Sutton R
Am J Physiol; 1988 Sep; 255(3 Pt 2):R368-72. PubMed ID: 2970806
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide and exaggerated natriuresis during acute hypertonic volume expansion in essential hypertension.
Sørensen SS; Danielsen H; Amdisen A; Pedersen EB
J Hypertens; 1989 Jan; 7(1):21-9. PubMed ID: 2523419
[TBL] [Abstract][Full Text] [Related]
11. Hormonal and circulatory responses to chronically controlled increments in right atrial pressure.
Shin Y; Lohmeier TE; Hester RL; Kivlighn SD; Smith MJ
Am J Physiol; 1991 Nov; 261(5 Pt 2):R1176-87. PubMed ID: 1835308
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-stimulated secretion of arginine vasopressin is inhibited by atrial natriuretic peptide in humans.
Matsukawa T; Miyamoto T
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R624-9. PubMed ID: 21123762
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide and blood volume in patients with chronic glomerulonephritis: effects of albumin and frusemide administration.
Jespersen B; Danielsen H; Pedersen EB
Nephrol Dial Transplant; 1990; 5(12):997-1006. PubMed ID: 1965738
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretic hormone secretion and with diabetes insipidus.
Kamoi K; Ebe T; Kobayashi O; Ishida M; Sato F; Arai O; Tamura T; Takagi A; Yamada A; Ishibashi M
J Clin Endocrinol Metab; 1990 May; 70(5):1385-90. PubMed ID: 2139879
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
Klemm SA; Tunny TJ; Gordon RD
J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
[TBL] [Abstract][Full Text] [Related]
16. Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
Nicola W; Sidhom G; El Khyat Z; Ibrahim S; Salah A; El Sayed A
Endocr J; 2001 Feb; 48(1):25-31. PubMed ID: 11403100
[TBL] [Abstract][Full Text] [Related]
17. [Regulation of thirst in end-stage kidney insufficiency].
Heidbreder E; Bahner U; Hess M; Geiger H; Götz R; Kirsten R; Rascher W; Heidland A
Klin Wochenschr; 1990 Nov; 68(22):1127-33. PubMed ID: 2149156
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic factor, angiotensin II, aldosterone, arginine vasopressin and urinary prostaglandin E2 excretion in hyperfiltrating unilaterally nephrectomized humans.
Sørensen SS; Jespersen B; Pedersen EB
Scand J Clin Lab Invest; 1990 Jun; 50(4):371-8. PubMed ID: 2144053
[TBL] [Abstract][Full Text] [Related]
19. Maternal and fetal atrial natriuretic peptide levels, maternal plasma renin activity, angiotensin II, prostacyclin and thromboxane A2 levels in normal and preeclamptic pregnancies.
Furuhashi N; Tsujiei M; Kimura H; Yajima A; Nagae H; Kimura C
Tohoku J Exp Med; 1991 Oct; 165(2):79-86. PubMed ID: 1839873
[TBL] [Abstract][Full Text] [Related]
20. Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome.
Watanabe H; Lau DC; Guyn HL; Wong NL
Clin Invest Med; 1997 Aug; 20(4):211-23. PubMed ID: 9258576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
